Functional Duality of Astrocytes in Myelination

Astrocytes undergo major phenotypic changes in response to injury and disease that directly influence repair in the CNS, but the mechanisms involved are poorly understood. Previously, we have shown that neurosphere-derived rat astrocytes plated on poly-l-lysine (PLL-astrocytes) support myelination in dissociated rat spinal cord cultures (myelinating cultures). It is hypothesized that astrocyte reactivity can affect myelination, so we have exploited this culture system to ascertain how two distinct astrocyte phenotypes influence myelination. Astrocytes plated on tenascin C (TnC-astrocytes), a method to induce quiescence, resulted in less myelinated fibers in the myelinating cultures when compared with PLL-astrocytes. In contrast, treatment of myelinating cultures plated on PLL-astrocytes with ciliary neurotrophic factor (CNTF), a cytokine known to induce an activated astrocyte phenotype, promoted myelination. CNTF could also reverse the effect of quiescent astrocytes on myelination. A combination of microarray gene expression analysis and quantitative real-time PCR identified CXCL10 as a potential candidate for the reduction in myelination in cultures on TnC-astrocytes. The effect of TnC-astrocytes on myelination was eliminated by neutralizing CXCL10 antibodies. Conversely, CXCL10 protein inhibited myelination on PLL-astrocytes. Furthermore, CXCL10 treatment of purified oligodendrocyte precursor cells did not affect proliferation, differentiation, or process extension compared with untreated controls, suggesting a role in glial/axonal ensheathment. These data demonstrate a direct correlation of astrocyte phenotypes with their ability to support myelination. This observation has important implications with respect to the development of therapeutic strategies to promote CNS remyelination in demyelinating diseases.

[1]  J. Higginson,et al.  The culture of olfactory ensheathing cells (OECs)—a distinct glial cell type , 2011, Experimental Neurology.

[2]  J. Newcombe,et al.  Extracellular Matrix in Multiple Sclerosis Lesions: Fibrillar Collagens, Biglycan and Decorin are Upregulated and Associated with Infiltrating Immune Cells , 2010, Brain pathology.

[3]  I. Campbell,et al.  Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity – a tale of conflict and conundrum , 2010, Neuropathology and applied neurobiology.

[4]  Kavya Reddy,et al.  Soluble Neuregulin-1 Has Bifunctional, Concentration-Dependent Effects on Schwann Cell Myelination , 2010, The Journal of Neuroscience.

[5]  M. Sofroniew,et al.  Astrocytes: biology and pathology , 2009, Acta Neuropathologica.

[6]  M. Sofroniew Molecular dissection of reactive astrogliosis and glial scar formation , 2009, Trends in Neurosciences.

[7]  C. ffrench-Constant,et al.  Tenascin C and tenascin R similarly prevent the formation of myelin membranes in a RhoA‐dependent manner, but antagonistically regulate the expression of myelin basic protein via a separate pathway , 2009, Glia.

[8]  M. Vingron,et al.  Paracrine control of oligodendrocyte differentiation by SRF-directed neuronal gene expression , 2009, Nature Neuroscience.

[9]  A. Sorenson,et al.  Myelinated, synapsing cultures of murine spinal cord – validation as an in vitro model of the central nervous system , 2008, The European journal of neuroscience.

[10]  S. Miller,et al.  Astrocytes in multiple sclerosis: A product of their environment , 2008, Cellular and Molecular Life Sciences.

[11]  S. Barnett,et al.  Astrocytes, but not olfactory ensheathing cells or Schwann cells, promote myelination of CNS axons in vitro , 2008, Glia.

[12]  Marcus Müller,et al.  Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN‐γ but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro , 2007, Glia.

[13]  Anna C. Williams,et al.  Astrocytes—Friends or foes in multiple sclerosis? , 2007, Glia.

[14]  I. Campbell,et al.  CXCR3 Signaling Reduces the Severity of Experimental Autoimmune Encephalomyelitis by Controlling the Parenchymal Distribution of Effector and Regulatory T Cells in the Central Nervous System1 , 2007, The Journal of Immunology.

[15]  S. Levison,et al.  CNTF-Activated Astrocytes Release a Soluble Trophic Activity for Oligodendrocyte Progenitors , 2007, Neurochemical Research.

[16]  I. Griffiths,et al.  Murine spinal cord explants: A model for evaluating axonal growth and myelination in vitro , 2006, Journal of neuroscience research.

[17]  J. Rothstein,et al.  Mechanisms of Disease: astrocytes in neurodegenerative disease , 2006, Nature Clinical Practice Neurology.

[18]  J. Turnbull,et al.  Intracellular trafficking in neurones and glia of fibroblast growth factor‐2, fibroblast growth factor receptor 1 and heparan sulphate proteoglycans in the injured adult rat cerebral cortex , 2006, Journal of neurochemistry.

[19]  N. Gutowski,et al.  Tenascin C induces a quiescent phenotype in cultured adult human astrocytes , 2005, Glia.

[20]  RAINER BREITLING,et al.  Rank-based Methods as a Non-parametric Alternative of the T-statistic for the Analysis of Biological Microarray Data , 2005, J. Bioinform. Comput. Biol..

[21]  M. Nilsson,et al.  Astrocyte activation and reactive gliosis , 2005, Glia.

[22]  S. Sealfon,et al.  CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis. , 2005, Brain : a journal of neurology.

[23]  D. Loy,et al.  Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes , 2005, Experimental Neurology.

[24]  C. Brosnan,et al.  IL‐1‐regulated responses in astrocytes: Relevance to injury and recovery , 2005, Glia.

[25]  Rainer Breitling,et al.  Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments , 2004, FEBS letters.

[26]  S. Levison,et al.  Pro‐regenerative properties of cytokine‐activated astrocytes , 2004, Journal of neurochemistry.

[27]  Ngan B. Doan,et al.  Reactive Astrocytes Protect Tissue and Preserve Function after Spinal Cord Injury , 2004, The Journal of Neuroscience.

[28]  Jerry Silver,et al.  Regeneration beyond the glial scar , 2004, Nature Reviews Neuroscience.

[29]  H. Weiner,et al.  IFN-Inducible Protein 10/CXC Chemokine Ligand 10-Independent Induction of Experimental Autoimmune Encephalomyelitis1 , 2004, The Journal of Immunology.

[30]  Jonathan R. Enterline,et al.  Astrocytes produce CNTF during the remyelination phase of viral-induced spinal cord demyelination to stimulate FGF-2 production , 2003, Neurobiology of Disease.

[31]  B. Stankoff,et al.  Ciliary Neurotrophic Factor (CNTF) Enhances Myelin Formation: A Novel Role for CNTF and CNTF-Related Molecules , 2002, The Journal of Neuroscience.

[32]  R. Ravid,et al.  Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system , 2002, Journal of Neuroimmunology.

[33]  L. Jasmin,et al.  Remyelination within the CNS: Do Schwann Cells Pave the Way for Oligodendrocytes? , 2002, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[34]  S. Barnett,et al.  Identification of growth factors that promote long‐term proliferation of olfactory ensheathing cells and modulate their antigenic phenotype , 2002, Glia.

[35]  T. Deller,et al.  CNTF and CNTF receptor alpha are constitutively expressed by astrocytes in the mouse brain , 2002, Glia.

[36]  S. Kunkel,et al.  EncephalomyelitisDuring Experimental Autoimmune Accumulation in the Central Nervous System T Cell + Control of Encephalitogenic CD4 -Inducible Protein-10) g CXCL10 (IFN-and , 2001 .

[37]  S. Kunkel,et al.  CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. , 2001, Journal of immunology.

[38]  G. Yancopoulos,et al.  The ciliary neurotrophic factor and its receptor, CNTFRα , 2000 .

[39]  S Rozen,et al.  Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.

[40]  M. Jurynec,et al.  The Chondroitin Sulfate Proteoglycans Neurocan and Phosphacan Are Expressed by Reactive Astrocytes in the Chronic CNS Glial Scar , 1999, The Journal of Neuroscience.

[41]  H. Weiner,et al.  CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Jakob S. Jensen,et al.  Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. , 1999, The Journal of clinical investigation.

[43]  A. Young,et al.  Cellular aspects of trophic actions in the nervous system. , 1999, International review of cytology.

[44]  I. Duncan,et al.  Generation of oligodendroglial progenitors from neural stem cells , 1998, Journal of neurocytology.

[45]  S. Levison,et al.  Ciliary neurotrophic factor stimulates astroglial hypertrophy in vivo and in vitro. , 1998, Experimental neurology.

[46]  S. K. Malhotra,et al.  Reactive astrocytes: cellular and molecular cues to biological function , 1997, Trends in Neurosciences.

[47]  C. ffrench-Constant,et al.  Expression and function of thrombospondin‐1 in myelinating glial cells of the central nervous system , 1997, Journal of neuroscience research.

[48]  C. Gall,et al.  Astroglial ciliary neurotrophic factor mRNA expression is increased in fields of axonal sprouting in deafferented hippocampus , 1997, The Journal of comparative neurology.

[49]  R. Ransohoff,et al.  Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. , 1997, The American journal of pathology.

[50]  M. Frotscher,et al.  Differential Regulation of Ciliary Neurotrophic Factor (CNTF) and CNTF Receptor α Expression in Astrocytes and Neurons of the Fascia Dentata after Entorhinal Cortex Lesion , 1997, The Journal of Neuroscience.

[51]  S. Weiss,et al.  Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. , 1996, Developmental biology.

[52]  R. Ransohoff,et al.  In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis. , 1996, The American journal of pathology.

[53]  P. Gray,et al.  Chemokine expression in murine experimental allergic encephalomyelitis , 1995, Journal of Neuroimmunology.

[54]  F. Gomez-Pinilla,et al.  Regulation of astrocyte proliferation by FGF-2 and heparan sulfate in vivo , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[55]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[56]  L. Eng,et al.  GFAP and Astrogliosis , 1994, Brain pathology.

[57]  M. Norenberg,et al.  Astrocyte Responses to CNS Injury , 1994, Journal of neuropathology and experimental neurology.

[58]  M. Eddleston,et al.  Molecular profile of reactive astrocytes—Implications for their role in neurologic disease , 1993, Neuroscience.

[59]  R. Ransohoff,et al.  Astrocyte expression of mRNA encoding cytokines IP‐10 and JE/MCP‐1 in experimental autoimmune encephalomyelitis , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[60]  P. Bovolenta,et al.  Differential activation of microglia and astrocytes in aniso‐ and isomorphic gliotic tissue , 1993, Glia.

[61]  H. Lassmann,et al.  The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement , 1991, Journal of Neuroimmunology.

[62]  H. Wekerle,et al.  Monoclonal Antibodies Against Myelin Proteolipid Protein: Identification and Characterization of Two Major Determinants , 1991, Journal of neurochemistry.

[63]  H. Thoenen,et al.  Regional distribution, developmental changes, and cellular localization of CNTF-mRNA and protein in the rat brain , 1991, The Journal of cell biology.

[64]  R. Franklin,et al.  Transplanted type-1 astrocytes facilitate repair of demyelinating lesions by host oligodendrocytes in adult rat spinal cord , 1991, Journal of neurocytology.

[65]  A. Crang,et al.  The relationship between type-1 astrocytes, Schwann cells and oligodendrocytes following transplantation of glial cell cultures into demyelinating lesions in the adult rat spinal cord , 1989, Journal of neurocytology.

[66]  M. Noble,et al.  Purified astrocytes promote the in vitro division of a bipotential glial progenitor cell. , 1984, The EMBO journal.

[67]  M. Raff,et al.  Tracing the development of oligodendrocytes from precursor cells using monoclonal antibodies, fluorescence-activated cell sorting, and cell culture. , 1983, Developmental biology.

[68]  M. Schachner,et al.  Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. , 1981, Developmental biology.

[69]  G H Sato,et al.  Growth of a rat neuroblastoma cell line in serum-free supplemented medium. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[70]  A. Rizzino,et al.  The growth of cells in serum-free hormone-supplemented media. , 1979, Methods in enzymology.

[71]  D. Duncan A relation between axone diameter and myelination determined by measurement of myelinated spinal root fibers , 1934 .